Elevance Health reported $201.8B of revenue over the trailing twelve months, +3.6% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $201.8B (to Q3 2026). Net income: $5.14B, trailing twelve months to Q3 2026. Free cash flow: $6.51B, trailing twelve months to Q3 2026. Operating margin: 2.7%, trailing twelve months to Q3 2026.

ELVElevance Health

Healthcare

$439.89+28% 1Y

$439.89

$277.8952 weeks$445.34

ELV as reported

Elevance Health reported $201.8B of revenue over the trailing twelve months, +3.6% on the year before. 11 reported series are charted on this page, each one as filed.

$201.8B

Revenue, trailing twelve months · to Q3 2026 · +3.6% against the twelve months before

Net income: $5.14B
Net income · −7.1% year on year · trailing twelve months to Q3 2026
Free cash flow: $6.51B
Free cash flow · +73% year on year · trailing twelve months to Q3 2026
Operating margin: 2.7%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for ELV, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$201.8B	+3.6%	Q3 2026
Net income	$5.14B	−7.1%	Q3 2026
EPS	$23.52	−4.1%	Q3 2026
Gross margin	89%	n/a	Q3 2026
Operating margin	2.7%	n/a	Q3 2026
Net margin	2.5%	n/a	Q3 2026
ROE	12%	n/a	Q3 2026
ROA	4.2%	n/a	Q3 2026
ROIC	12%	n/a	Q3 2026
Free cash flow	$6.51B	+73%	Q3 2026
P/E	18.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.